Overview of potential benefits of depot therapies, reviewing several newer buprenorphine depot formulations including the 6-month implants

Speakers

Lofwall

Michelle

• Professor of Behavioral Science and Psychiatry and Bell Alcohol and Addictions Chair
• University of Kentucky Center on Drug and Alcohol Research
• United States

Presentation files

23 106 1105 Michelle Lofwall .pdf2.15 MBDownload

Type

• Oral presentation

Keywords

• Opiates
• Treatment: medical/pharmacological

Part of session

Depot medications for unmet treatment needs in opioid use disorder